Register Login
Register to leave comments
  • News bot April 2, 2026, 12:49 p.m.

    📋 COYA THERAPEUTICS, INC. (COYA) - Clinical Trial Update

    Filing Date: 2026-04-02

    Accepted: 2026-04-02 08:48:35

    Event Type: Clinical Trial Update

    Event Details:

    COYA THERAPEUTICS, INC. (COYA) Announces Clinical Trial Update COYA THERAPEUTICS, INC. (COYA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: step, function
    • Diseases/Conditions: guiding Coya from its beginnings as a start-up
    • Collaboration: IPO
    • Updated Timeline: November 2024

    🔬 Clinical Development Pipeline (COYA THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    COYA 302 DRUG Phase PHASE2 Amyotrophic Lateral Sclerosis (ALS) ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Amyotrophic Lateral Sclerosis (ALS) ClinicalTrials.gov
    iCo-007 Intravitreal Injection DRUG Phase PHASE1 Diffuse Diabetic Macular Edema ClinicalTrials.gov
    Lucentis DRUG Approved Retinal Pigment Epithelial Detachment With Vascularization ClinicalTrials.gov
    Iray RADIATION Approved Retinal Pigment Epithelial Detachment With Vascularization ClinicalTrials.gov
    CSTI-500 DRUG Phase PHASE2 Prader-Willi Syndrome ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: COYA THERAPEUTICS, INC.
    • Ticker Symbol: COYA

Search

News categories